Sreedhar Reddy Suthe

RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Sreedhar Reddy Suthe, Hangping Yao, Tian-Hao Weng et al. · Molecular Cancer Therapeutics · 2018 · 27 citations · Full text

Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase

Hangping Yao, Liang Feng, Tian-Hao Weng et al. · Molecular Pharmaceutics · 2018 · 25 citations

Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability

Jaewon Lee, Liping Yang, Mary Beth Hilton et al. · Cell Reports · 2023 · 24 citations · Full text

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

Xiang-Min Tong, Liang Feng, Sreedhar Reddy Suthe et al. · Journal for ImmunoTherapy of Cancer · 2019 · 23 citations · Full text

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Hangping Yao, Liang Feng, Sreedhar Reddy Suthe et al. · Journal for ImmunoTherapy of Cancer · 2019 · 23 citations · Full text